Scaling cell therapy supply chains during a pandemic

Achieving donor pool sustainability and cell therapy supply chain success

Subscribe

Get updates from the Cell Lines Blog delivered to your inbox.

Being an NMDP/Be The Match courier during COVID-19

Making essential treatments possible in the midst of a pandemic

How CAR-T reimbursement discussions help advance the field

Proposed IPPS rule an encouraging step towards a clearer payment process

Be The Match BioTherapies CEO’s path to biotech

How a personal experience led her on a mission to save lives through cellular therapy

5 Qualities to Seek in Your Cell Therapy Supply Chain Vendor

Considerations to help lower your cell or gene therapy logistics risk

Overcoming autologous cell therapy logistics challenges in the age of COVID-19

Experienced team for managed logistics is key

Can cell therapies unlock the COVID-19 mystery?

The promise of MSC therapies to treat deadly manifestations of cytokine storms

How COVID-19 is changing the production of cell therapies

Implementation of contingency plans allows for continued progress in therapy development

Managing donor collections during the COVID-19 pandemic

Why a diverse apheresis center network is critical to business continuity